tiprankstipranks
Advertisement
Advertisement
CanSino Wins China Nod to Extend Use of Menhycia Pediatric Vaccine
PremiumCompany AnnouncementsCanSino Wins China Nod to Extend Use of Menhycia Pediatric Vaccine
2M ago
CanSino Biologics Forecasts 2025 Revenue Growth and Return to Profit
Premium
Company Announcements
CanSino Biologics Forecasts 2025 Revenue Growth and Return to Profit
3M ago
CanSino Wins China Trial Nod for First-in-Class 24-Valent Pneumococcal Vaccine
Premium
Company Announcements
CanSino Wins China Trial Nod for First-in-Class 24-Valent Pneumococcal Vaccine
3M ago
CanSino Biologics to Offset Losses with Reserves
PremiumCompany AnnouncementsCanSino Biologics to Offset Losses with Reserves
5M ago
CanSino Biologics Enhances Governance with New Committee
Premium
Company Announcements
CanSino Biologics Enhances Governance with New Committee
6M ago
CanSino Biologics Proposes Governance Restructuring
Premium
Company Announcements
CanSino Biologics Proposes Governance Restructuring
6M ago
CanSino Biologics to Review Q3 Financial Results
PremiumCompany AnnouncementsCanSino Biologics to Review Q3 Financial Results
6M ago
CanSino Biologics Announces 2025 Extraordinary General Meeting to Discuss Incentive Schemes
Premium
Company Announcements
CanSino Biologics Announces 2025 Extraordinary General Meeting to Discuss Incentive Schemes
6M ago
CanSino Biologics Clarifies 2025 H Share Option Scheme Details
Premium
Company Announcements
CanSino Biologics Clarifies 2025 H Share Option Scheme Details
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100